跳到正文
原文
Endpoints News 生物医药· Nicole DeFeudis·· 10 天前AI 评分40

Mirum 计划向 FDA 提交肝炎 D 治疗药物申请

Mirum plans FDA submission for hepatitis D treatment as competition brews

AI 导读

Mirum 的肝炎 D 治疗药物在第二项关键临床试验中取得成功,现正准备向 FDA 提交申请,面临其他竞争产品的挑战。

正文

Mirum’s he­pati­tis D treat­ment has suc­ceed­ed in the sec­ond of two piv­otal tri­als. Now comes the next chal­lenge: com­pet­ing with ri­vals in a grow­ing mar­ket.

…

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news